LENSAR (NASDAQ:LNSR) Cut to “Hold” at Wall Street Zen

Wall Street Zen cut shares of LENSAR (NASDAQ:LNSR) from a buy rating to a hold rating in a report released on Saturday,Wall Street Zen reports.

A number of other equities analysts have also weighed in on the company. Loop Capital set a $11.00 target price on LENSAR in a research report on Monday, September 28th. Lake Street Capital reaffirmed a “buy” rating and set a $13.00 price target on shares of LENSAR in a report on Thursday, August 13th. Weiss Ratings lowered shares of LENSAR from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, August 21st. Finally, BTIG Research boosted their price objective on shares of LENSAR from $9.00 to $10.00 and gave the company a “buy” rating in a report on Thursday, August 20th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, LENSAR presently has a consensus rating of “Hold” and a consensus target price of $11.33.

LENSAR Trading Down 1.2%

LENSAR stock opened at $6.67 on Friday. The firm has a market cap of $81.97 million, a price-to-earnings ratio of -20.21 and a beta of 0.95. The stock has a fifty day simple moving average of $7.32 and a two-hundred day simple moving average of $6.32. LENSAR has a 12 month low of $4.95 and a 12 month high of $12.94.

LENSAR (NASDAQ:LNSR) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.26. LENSAR had a negative return on equity of 529.08% and a net margin of 57.57%.The firm had revenue of $16.50 million for the quarter, compared to the consensus estimate of $14.65 million.

Institutional Trading of LENSAR

A number of hedge funds have recently bought and sold shares of the company. Bank of New York Mellon Corp purchased a new position in LENSAR in the second quarter worth about $58,000. Engineers Gate Manager LP purchased a new stake in shares of LENSAR during the 2nd quarter valued at about $63,000. Sanctuary Advisors LLC bought a new position in shares of LENSAR in the 2nd quarter worth approximately $96,000. Royal Bank of Canada lifted its stake in shares of LENSAR by 78.2% in the 1st quarter. Royal Bank of Canada now owns 20,095 shares of the company’s stock worth $120,000 after purchasing an additional 8,818 shares during the period. Finally, Gamco Investors INC. ET AL boosted its holdings in shares of LENSAR by 10.0% in the first quarter. Gamco Investors INC. ET AL now owns 33,000 shares of the company’s stock worth $197,000 after buying an additional 3,000 shares during the last quarter. Hedge funds and other institutional investors own 40.15% of the company’s stock.

LENSAR Company Profile

LENSAR, Inc is a medical device company focused on technology for cataract and refractive eye surgery. The company develops and commercializes femtosecond laser systems designed to assist ophthalmic surgeons with key steps of cataract procedures, including corneal incisions, arcuate incisions and lens fragmentation.

Its product portfolio includes the LENSAR Laser System, which combines femtosecond laser technology with three-dimensional imaging and software intended to support customized treatment planning.